Vertebral osteomyelitis: an analysis of 38 surgically treated cases

European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
H MatsuiY Sakaguchi

Abstract

The purpose of the study was to evaluate the characteristics of patients with vertebral osteomyelitis who were treated by anterior debridement and interbody fusion. Thirty-eight patients with vertebral osteomyelitis, who were treated between 1980 and 1993, were analyzed in terms of age at the occurrence of disease, duration of disease, type of onset symptoms, radiological type of vertebral destruction, species of pathogen, and surgical result. Thirty-one out of 38 patients (82%) were more than 40 years of age. The patients with severe vertebral destruction were significantly older than those with mild vertebral destruction. Vertebral destruction in the thoracic spine was significantly more severe than that in the lumbar spine. Staphylococcus aureus was identified in only six patients (32% of organism-determined cases). In the present patients who required anterior debridement and bone grafting for this disease, the prognosis was quite good after anterior interbody fusion in conjunction with antibiotics therapy.

Citations

Oct 29, 2011·International Orthopaedics·W Y Cheung, Keith D K Luk
Sep 10, 2003·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·U LiljenqvistW Winkelmann
May 6, 2009·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·N BettiniS Cervellati
Apr 12, 2008·Spine·Brendan J O'DalyS Kieran O'Rourke
Jan 5, 2007·Internal Medicine·Takuhiro MoromizatoYasuharu Tokuda
Jun 3, 2010·Journal of Neurosurgery. Spine·Mahmoud RayesHazem A Eltahawy
Jan 8, 2005·Neurosurgical Focus·Frank L AcostaDean Chou
Jan 8, 2005·Neurosurgical Focus·Alfred T Ogden, Michael G Kaiser
Apr 20, 2014·Case Reports in Orthopedics·Mehmet Nuri ErdemMehmet Tezer
Aug 1, 2014·Clinical Neurology and Neurosurgery·Ming-xiang ZouYou-wen Deng
Jun 14, 2008·Seminars in Arthritis and Rheumatism·E MylonaA Skoutelis
Aug 1, 2006·Neurosurgery Clinics of North America·Jorge J Jaramillo-de la TorreCharles Kuntz
Dec 21, 2005·Journal of Orthopaedic Surgery·A NatherJ Thambiah

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
U LiljenqvistW Winkelmann
Journal of Spinal Disorders & Techniques
Ralph C SchimmerBernard Jeanneret
© 2022 Meta ULC. All rights reserved